Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 16126 - 16150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Carmustine	Approved Investigational	KRT17	3872	downregulated	Carmustine results in decreased expression of KRT17 mRNA	17q21.2	A21555
Carmustine	Approved Investigational	KRT31	3881	downregulated	Carmustine results in decreased expression of KRT31 mRNA	17q21.2	A21555
Carmustine	Approved Investigational	LAD1	3898	downregulated	Carmustine results in decreased expression of LAD1 mRNA	1q32.1	A21555
Carmustine	Approved Investigational	LAIR1	3903	upregulated	Carmustine results in increased expression of LAIR1 mRNA	19q13.42	A21555
Carmustine	Approved Investigational	LAMB3	3914	downregulated	Carmustine results in decreased expression of LAMB3 mRNA	1q32.2	A21555
Carmustine	Approved Investigational	LMX1B	4010	downregulated	Carmustine results in decreased expression of LMX1B mRNA	9q33.3	A21555
Carmustine	Approved Investigational	LOXL1	4016	downregulated	Carmustine results in decreased expression of LOXL1 mRNA	15q24.1	A21555
Carmustine	Approved Investigational	LRCH4	4034	downregulated	Carmustine results in decreased expression of LRCH4 mRNA	7q22.1	A21555
Carmustine	Approved Investigational	LRMP	4033	downregulated	Carmustine results in decreased expression of LRMP mRNA	12p12.1	A21555
Carmustine	Approved Investigational	MAD1L1	8379	downregulated	Carmustine results in decreased expression of MAD1L1 mRNA	7p22.3	A21555
Carmustine	Approved Investigational	MAP4K2	5871	downregulated	Carmustine results in decreased expression of MAP4K2 mRNA	11q13.1	A21555
Carmustine	Approved Investigational	MAPK10	5602	downregulated	Carmustine results in decreased expression of MAPK10 mRNA	4q21.3	A21555
Carmustine	Approved Investigational	MAT1A	4143	downregulated	Carmustine results in decreased expression of MAT1A mRNA	10q22.3	A21555
Carmustine	Approved Investigational	MDK	4192	downregulated	Carmustine results in decreased expression of MDK mRNA	11p11.2	A21555
Carmustine	Approved Investigational	MED1	5469	downregulated	Carmustine results in decreased expression of MED1 mRNA	17q12	A21555
Carmustine	Approved Investigational	MGAT3	4248	downregulated	Carmustine results in decreased expression of MGAT3 mRNA	22q13.1	A21555
Carmustine	Approved Investigational	MSR1	4481	downregulated	Carmustine results in decreased expression of MSR1 mRNA	8p22	A21555
Carmustine	Approved Investigational	MUC2	4583	downregulated	Carmustine results in decreased expression of MUC2 mRNA	11p15.5	A21555
Carmustine	Approved Investigational	MVD	4597	downregulated	Carmustine results in decreased expression of MVD mRNA	16q24.2	A21555
Carmustine	Approved Investigational	MYBPH	4608	downregulated	Carmustine results in decreased expression of MYBPH mRNA	1q32.1	A21555
Carmustine	Approved Investigational	MYD88	4615	downregulated	Carmustine results in decreased expression of MYD88 mRNA	3p22.2	A21555
Carmustine	Approved Investigational	MYOD1	4654	downregulated	Carmustine results in decreased expression of MYOD1 mRNA	11p15.1	A21555
Carmustine	Approved Investigational	MYOG	4656	downregulated	Carmustine results in decreased expression of MYOG mRNA	1q32.1	A21555
Carmustine	Approved Investigational	NDUFC1	4717	downregulated	Carmustine results in decreased expression of NDUFC1 mRNA	4q31.1	A21555
Carmustine	Approved Investigational	NKX2-2	4821	downregulated	Carmustine results in decreased expression of NKX2-2 mRNA	20p11.22	A21555

Displaying entries 16126 - 16150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability